Literature DB >> 18982422

Pharmacological differences between once daily and twice daily gentamicin dosage in newborns with suspected sepsis.

Inge Hagen1, Knut Øymar.   

Abstract

OBJECTIVE: To evaluate two different regimens for gentamicin administration (once or twice daily) in newborns with suspected sepsis, and the ability of these regimens to achieve recommended serum gentamicin concentrations (SGC) within the therapeutic range. Setting Neonatal intensive care unit.
METHOD: We conducted a retrospective study of newborns > or =34 weeks gestational age (GA) admitted with suspected sepsis to the neonatal unit at Stavanger University Hospital from 1st February 2003 to 31st May 2005. During the first period patients received gentamicin 2.5 mg/kg twice daily (n = 62) and during the last period patients received gentamicin 4 mg/kg once daily (n = 73). In both groups, levels of gentamicin were obtained before and after the third given dose.
RESULTS: Mean peak levels were lower and mean trough levels were higher in the twice daily regimen compared to the once daily regimen (P < 0.001 for both). About 16 newborns in the twice daily regimen had trough levels higher than the recommended level (<2 microg/ml) compared to two children in the once daily regimen (P < 0.001). High peak levels (>10 microg/ml) were achieved in one child in the twice daily regimen compared to eight children in the once daily regimen (P = 0.04). The number of children with a low peak level (<5 microg/ml) was only three and one respectively (n.s).
CONCLUSION: In newborns with suspected sepsis, gentamicin 4 mg/kg once daily provided higher peak and lower trough gentamicin levels compared to administering gentamicin 2.5 mg twice daily.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18982422     DOI: 10.1007/s11096-008-9255-y

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  19 in total

1.  Rationing antibiotic use in neonatal units.

Authors:  D Isaacs
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-01       Impact factor: 5.747

Review 2.  Newborns and gentamicin--how much and how often?

Authors:  B Chattopadhyay
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

3.  Comparison of once-daily versus twice-daily gentamicin dosing regimens in infants > or = 2500 g.

Authors:  Ghanshyam Agarwal; Alok Rastogi; Suma Pyati; Angela Wilks; Rosita S Pildes
Journal:  J Perinatol       Date:  2002-06       Impact factor: 2.521

4.  Gentamicin dosing in neonatal patients.

Authors:  N Gooding; A Elias-Jones; M Shenoy
Journal:  Pharm World Sci       Date:  2001-10

5.  The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

Authors:  R D Moore; C R Smith; P S Lietman
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

Review 6.  Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis.

Authors:  E Nestaas; H-J Bangstad; L Sandvik; K-O Wathne
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-04-27       Impact factor: 5.747

7.  Once- versus twice-daily gentamicin dosing in neonates >/=34 Weeks' gestation: cost-effectiveness analyses.

Authors:  P J Thureen; P D Reiter; A Gresores; N M Stolpman; K Kawato; D M Hall
Journal:  Pediatrics       Date:  1999-03       Impact factor: 7.124

8.  Once daily gentamicin dosing in full term neonates.

Authors:  Saad A Alsaedi
Journal:  Saudi Med J       Date:  2003-09       Impact factor: 1.484

9.  Extended-interval aminoglycoside administration for children: a meta-analysis.

Authors:  Despina G Contopoulos-Ioannidis; Nikos D Giotis; Dimitra V Baliatsa; John P A Ioannidis
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

10.  "Random" gentamicin concentrations do not predict trough levels in neonates receiving once daily fixed dose regimens.

Authors:  Elaine M Boyle; Isobel Brookes; Kathy Nye; Mike Watkinson; F Andrew I Riordan
Journal:  BMC Pediatr       Date:  2006-03-17       Impact factor: 2.125

View more
  3 in total

1.  Off-label antibiotic use in children in three European countries.

Authors:  Alessandro Porta; Susanna Esposito; Esse Menson; Nikos Spyridis; Maria Tsolia; Mike Sharland; Nicola Principi
Journal:  Eur J Clin Pharmacol       Date:  2010-06-08       Impact factor: 2.953

Review 2.  One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.

Authors:  Shripada C Rao; Ravisha Srinivasjois; Kwi Moon
Journal:  Cochrane Database Syst Rev       Date:  2016-12-06

3.  Prevalence and nature of off-label antibiotic prescribing for children in a tertiary setting: A descriptive study from Jordan.

Authors:  Tareq L Mukattash; Wail A Hayajneh; Shorok M Ibrahim; Abeer Ayoub; Nehad Ayoub; Anan S Jarab; Maher Khdour; Ammar Almaaytah
Journal:  Pharm Pract (Granada)       Date:  2016-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.